Authors: Zhu Zhengfei et al. Fudan University Shanghai Cancer Center Translated by: Kong Yuehong Reviewed by: Zhang Liyuan PRaG Treatment Center, The Second Affiliated Hospital of Soochow University Advanced driver…
Source of Research Article: Cao C, Wang L, Jiang F, et al. Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma. Neoplasia. 2025; 47:101156. Recently, the research team led by Professor Chen…
A new multicenter Phase II clinical trial, led by researchers from several institutions including Jiangsu Cancer Hospital, is showing promising results in treating patients with advanced metastatic solid tumors. This…
An Innovative Hope for Pancreatic Cancer: A Case Study of PRaG 3.0 Therapy Pancreatic cancer is one of the deadliest forms of cancer, and when it spreads, it becomes even…
Introduction: A New Hope for Metastatic Gastric Cancer Gastric cancer (GC) is one of the most common and deadly cancers globally, especially in countries like China, where it accounts for…
Introduction to Thyroid Hürthle Cell Carcinoma and Its Challenges Thyroid cancer is the most common type of endocrine cancer, and among its subtypes, Hürthle cell carcinoma (HCC) is rare but…
Metastatic triple-negative breast cancer (mTNBC) presents a formidable challenge due to its aggressive nature and poor prognosis. Despite numerous therapeutic approaches, such as surgery, chemotherapy, and radiotherapy, many patients with…
Cancer treatment is a field where no two journeys are the same. The case of advanced malignant perivascular epithelioid cell neoplasm (PEComa), as described in this report, brings to light…
Introduction: The Ongoing Struggle Against Metastatic Colon Cancer As I read through the case of a metastatic colon cancer patient, it hit me how relentless and unforgiving this disease can…
Introduction: The Challenge of Platinum-Resistant Ovarian CancerOvarian cancer, particularly in its platinum-resistant form, remains one of the most challenging gynecologic cancers to treat. Typically diagnosed at advanced stages, ovarian cancer’s…
Introduction: A New Hope for Refractory Metastatic ESCCEsophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer with a poor prognosis, often diagnosed at an advanced stage. Traditional treatment options,…
Introduction: A Breakthrough in Metastatic Gastric Cancer TreatmentGastric cancer, particularly when metastatic, often presents with a poor prognosis, especially when conventional therapies have failed. Patients who cannot tolerate chemotherapy due…
Introduction: Overcoming Resistance in Cancer TreatmentCancer therapy has come a long way in recent years, with immunotherapies, such as PD-1 inhibitors, showing great promise. However, resistance to these treatments remains…
If you are someone who follows developments in cancer treatment, especially in the realm of immunotherapy and radiotherapy, you may find the study titled “PD-1 Inhibitor Combined with Radiotherapy and…
PRaG therapy is an innovative cancer treatment regimen that based on radiotherapy, PD-1/PD-L1 inhibitors, and granulocyte-macrophage colony-stimulating factor (GM-CSF) to enhance the body’s immune response against tumors. This approach aims…